Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities.
暂无分享,去创建一个
D. Guillarme | Yannis-Nicolas François | S. Cianférani | V. D’Atri | A. Beck | S. Fekete | Amarande Murisier | Alexandre Goyon | Olivier Colas | Elsa Wagner | S. Chenu